Reliability of DHPLC in mutational screening of β-globin (HBB) alleles

Alessia Colosimo, Valentina Guida, Alessandro De Luca, Maria Pia Cappabianca, Ida Bianco, Giandomenico Palka, Bruno Dallapiccola

Research output: Contribution to journalArticle

Abstract

The inherited disorders of hemoglobin represent the most common Mendelian disease worldwide, with a higher prevalence among Mediterraneans, Asians, Africans, and Indians. Altered β-globin sequences, causing either hemoglobinopathies or β-thalassemia syndromes, are due to more than 200 different mutations in the β-globin gene. Prevention programs based on postnatal and prenatal molecular diagnosis of heterozygous carriers and/or patients require the use of reliable mutation scanning methods in at-risk populations. We have developed a rapid and highly specific mutation screening test based on the denaturing high-performance liquid chromatography (DHPLC) system. The sensitivity and specificity of the method were tested on the full genomic region of the β-globin gene in 30 normal Italian subjects and 40 heterozygous carriers in which 25 different β-globin mutations had been previously characterized by multiplex. ARMS technique. The results showed DHPLC to be 100% sensitive and specific. All the 25 sequence alterations and two previously undetected polymorphisms were precisely identified with neither false positive nor false negative results. In addition, 12 compound heterozygous and four homozygous patients were successfully subjected to DHPLC. Overall, the method was able to rapidly identify the most common β-globin mutations, accounting for more than 97% of β-globin alleles in the Italian population. Compared to classical approaches of mutation screening, this method allows a rapid, highly sensitive, cost-effective, and semi-automated simultaneous mutational scanning of a large number of samples.

Original languageEnglish
Pages (from-to)287-295
Number of pages9
JournalHuman Mutation
Volume19
Issue number3
DOIs
Publication statusPublished - 2002

Fingerprint

Globins
Alleles
High Pressure Liquid Chromatography
Mutation
Hemoglobinopathies
Thalassemia
Prenatal Diagnosis
Genes
Hemoglobins
Costs and Cost Analysis
Sensitivity and Specificity
Population

Keywords

  • β-globin
  • β-thalassemia
  • ARMS
  • Betaglobin
  • DHPLC
  • HBB
  • Mutation screening

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Reliability of DHPLC in mutational screening of β-globin (HBB) alleles. / Colosimo, Alessia; Guida, Valentina; De Luca, Alessandro; Cappabianca, Maria Pia; Bianco, Ida; Palka, Giandomenico; Dallapiccola, Bruno.

In: Human Mutation, Vol. 19, No. 3, 2002, p. 287-295.

Research output: Contribution to journalArticle

Colosimo, Alessia ; Guida, Valentina ; De Luca, Alessandro ; Cappabianca, Maria Pia ; Bianco, Ida ; Palka, Giandomenico ; Dallapiccola, Bruno. / Reliability of DHPLC in mutational screening of β-globin (HBB) alleles. In: Human Mutation. 2002 ; Vol. 19, No. 3. pp. 287-295.
@article{0f7a46bad8cb44ffbb91486de53a932b,
title = "Reliability of DHPLC in mutational screening of β-globin (HBB) alleles",
abstract = "The inherited disorders of hemoglobin represent the most common Mendelian disease worldwide, with a higher prevalence among Mediterraneans, Asians, Africans, and Indians. Altered β-globin sequences, causing either hemoglobinopathies or β-thalassemia syndromes, are due to more than 200 different mutations in the β-globin gene. Prevention programs based on postnatal and prenatal molecular diagnosis of heterozygous carriers and/or patients require the use of reliable mutation scanning methods in at-risk populations. We have developed a rapid and highly specific mutation screening test based on the denaturing high-performance liquid chromatography (DHPLC) system. The sensitivity and specificity of the method were tested on the full genomic region of the β-globin gene in 30 normal Italian subjects and 40 heterozygous carriers in which 25 different β-globin mutations had been previously characterized by multiplex. ARMS technique. The results showed DHPLC to be 100{\%} sensitive and specific. All the 25 sequence alterations and two previously undetected polymorphisms were precisely identified with neither false positive nor false negative results. In addition, 12 compound heterozygous and four homozygous patients were successfully subjected to DHPLC. Overall, the method was able to rapidly identify the most common β-globin mutations, accounting for more than 97{\%} of β-globin alleles in the Italian population. Compared to classical approaches of mutation screening, this method allows a rapid, highly sensitive, cost-effective, and semi-automated simultaneous mutational scanning of a large number of samples.",
keywords = "β-globin, β-thalassemia, ARMS, Betaglobin, DHPLC, HBB, Mutation screening",
author = "Alessia Colosimo and Valentina Guida and {De Luca}, Alessandro and Cappabianca, {Maria Pia} and Ida Bianco and Giandomenico Palka and Bruno Dallapiccola",
year = "2002",
doi = "10.1002/humu.10046",
language = "English",
volume = "19",
pages = "287--295",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Reliability of DHPLC in mutational screening of β-globin (HBB) alleles

AU - Colosimo, Alessia

AU - Guida, Valentina

AU - De Luca, Alessandro

AU - Cappabianca, Maria Pia

AU - Bianco, Ida

AU - Palka, Giandomenico

AU - Dallapiccola, Bruno

PY - 2002

Y1 - 2002

N2 - The inherited disorders of hemoglobin represent the most common Mendelian disease worldwide, with a higher prevalence among Mediterraneans, Asians, Africans, and Indians. Altered β-globin sequences, causing either hemoglobinopathies or β-thalassemia syndromes, are due to more than 200 different mutations in the β-globin gene. Prevention programs based on postnatal and prenatal molecular diagnosis of heterozygous carriers and/or patients require the use of reliable mutation scanning methods in at-risk populations. We have developed a rapid and highly specific mutation screening test based on the denaturing high-performance liquid chromatography (DHPLC) system. The sensitivity and specificity of the method were tested on the full genomic region of the β-globin gene in 30 normal Italian subjects and 40 heterozygous carriers in which 25 different β-globin mutations had been previously characterized by multiplex. ARMS technique. The results showed DHPLC to be 100% sensitive and specific. All the 25 sequence alterations and two previously undetected polymorphisms were precisely identified with neither false positive nor false negative results. In addition, 12 compound heterozygous and four homozygous patients were successfully subjected to DHPLC. Overall, the method was able to rapidly identify the most common β-globin mutations, accounting for more than 97% of β-globin alleles in the Italian population. Compared to classical approaches of mutation screening, this method allows a rapid, highly sensitive, cost-effective, and semi-automated simultaneous mutational scanning of a large number of samples.

AB - The inherited disorders of hemoglobin represent the most common Mendelian disease worldwide, with a higher prevalence among Mediterraneans, Asians, Africans, and Indians. Altered β-globin sequences, causing either hemoglobinopathies or β-thalassemia syndromes, are due to more than 200 different mutations in the β-globin gene. Prevention programs based on postnatal and prenatal molecular diagnosis of heterozygous carriers and/or patients require the use of reliable mutation scanning methods in at-risk populations. We have developed a rapid and highly specific mutation screening test based on the denaturing high-performance liquid chromatography (DHPLC) system. The sensitivity and specificity of the method were tested on the full genomic region of the β-globin gene in 30 normal Italian subjects and 40 heterozygous carriers in which 25 different β-globin mutations had been previously characterized by multiplex. ARMS technique. The results showed DHPLC to be 100% sensitive and specific. All the 25 sequence alterations and two previously undetected polymorphisms were precisely identified with neither false positive nor false negative results. In addition, 12 compound heterozygous and four homozygous patients were successfully subjected to DHPLC. Overall, the method was able to rapidly identify the most common β-globin mutations, accounting for more than 97% of β-globin alleles in the Italian population. Compared to classical approaches of mutation screening, this method allows a rapid, highly sensitive, cost-effective, and semi-automated simultaneous mutational scanning of a large number of samples.

KW - β-globin

KW - β-thalassemia

KW - ARMS

KW - Betaglobin

KW - DHPLC

KW - HBB

KW - Mutation screening

UR - http://www.scopus.com/inward/record.url?scp=0036186858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036186858&partnerID=8YFLogxK

U2 - 10.1002/humu.10046

DO - 10.1002/humu.10046

M3 - Article

C2 - 11857746

AN - SCOPUS:0036186858

VL - 19

SP - 287

EP - 295

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 3

ER -